A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits
- PMID: 12134005
- PMCID: PMC155148
- DOI: 10.1128/jvi.76.16.8003-8010.2002
A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits
Abstract
Following primary ocular infection, herpes simplex virus type 1 (HSV-1) establishes a lifelong latent infection in sensory neurons of the trigeminal ganglia. Latency-associated transcript (LAT), the only known viral gene abundantly transcribed during HSV-1 neuronal latency, is required for high levels of reactivation. Recently we showed that three different mutants that do not alter the LAT promoter but contain deletions within the 5' end of the primary LAT transcript affect viral virulence (G. C. Perng et al., J. Virol. 75:9018-9028, 2001). In contrast, in LAT-null mutants viral virulence appears unaltered (T. M. Block et al., Virology 192:618-630, 1993; D. C. Bloom et al., J. Virol. 68:1283-1292, 1994; J. M. Hill et al., Virology 174:117-125, 1990; G. C. Perng et al., J. Virol. 68:8045-8055, 1994; F. Sedarati, K. M. Izumi, E. K. Wagner, and J. G. Stevens, J. Virol. 63:4455-4458, 1989). We therefore hypothesized that the 5' end of LAT and/or an as yet unidentified gene that overlaps part of this region is involved in viral virulence. We report here on the discovery and initial characterization of a novel HSV-1 RNA consistent with such a putative gene. The novel RNA was antisense to the 5' end of LAT and was designated AL-RNA (anti-LAT sense RNA). The AL-RNA overlapped the core LAT promoter and the first 158 nucleotides of the 5' end of the primary LAT transcript. AL-RNA was detected in extracts from neuron-like cells (PC-12) infected with wild-type HSV-1 but not in cells infected with a mutant with the AL region deleted. The deletions in each of the above three mutants with altered virulence encompass the 5' end of the AL-RNA, and these mutants cannot transcribe AL. This supports the hypothesis that the AL gene may play a role in viral virulence. Based on comparison to the corresponding genomic sequence, the AL-RNA did not appear to be spliced. The AL-RNA was polyadenylated and contained an open reading frame capable of encoding a protein 56 amino acids in length with a predicted molecular mass of 6.8 kDa. Sera from three of three rabbits infected with wild-type HSV-1 but not sera from any of three rabbits infected with a mutant with the AL-RNA region deleted recognized the Escherichia coli recombinantly expressed AL open reading frame on Western blots. In addition, four of six rabbits infected with wild-type virus developed enzyme-linked immunosorbent assay titers against one or more AL synthetic peptides. These results suggest that an AL protein is produced in vivo.
Figures






Similar articles
-
A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels.J Virol. 2002 Feb;76(3):1224-35. doi: 10.1128/jvi.76.3.1224-1235.2002. J Virol. 2002. PMID: 11773398 Free PMC article.
-
Identification of a protein encoded in the herpes simplex virus type 1 latency associated transcript promoter region.Virus Res. 2005 Mar;108(1-2):101-10. doi: 10.1016/j.virusres.2004.08.011. Virus Res. 2005. PMID: 15681060
-
The spontaneous reactivation function of the herpes simplex virus type 1 LAT gene resides completely within the first 1.5 kilobases of the 8.3-kilobase primary transcript.J Virol. 1996 Feb;70(2):976-84. doi: 10.1128/JVI.70.2.976-984.1996. J Virol. 1996. PMID: 8551638 Free PMC article.
-
HSV LAT and neuronal survival.Int Rev Immunol. 2004 Jan-Apr;23(1-2):187-98. doi: 10.1080/08830180490265592. Int Rev Immunol. 2004. PMID: 14690860 Review.
-
Bovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting Apoptosis.J Cell Death. 2013 Apr 9;6:1-16. doi: 10.4137/JCD.S10803. eCollection 2013. J Cell Death. 2013. PMID: 25278776 Free PMC article. Review.
Cited by
-
Blockade of LAG-3 Immune Checkpoint Combined With Therapeutic Vaccination Restore the Function of Tissue-Resident Anti-viral CD8+ T Cells and Protect Against Recurrent Ocular Herpes Simplex Infection and Disease.Front Immunol. 2018 Dec 17;9:2922. doi: 10.3389/fimmu.2018.02922. eCollection 2018. Front Immunol. 2018. PMID: 30619285 Free PMC article.
-
Identification of a novel bovine herpesvirus 1 transcript containing a small open reading frame that is expressed in trigeminal ganglia of latently infected cattle.J Virol. 2004 May;78(10):5438-47. doi: 10.1128/jvi.78.10.5438-5447.2004. J Virol. 2004. PMID: 15113922 Free PMC article.
-
A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.J Immunol. 2010 Mar 1;184(5):2561-71. doi: 10.4049/jimmunol.0902322. Epub 2010 Feb 1. J Immunol. 2010. PMID: 20124097 Free PMC article.
-
The latency-associated transcript locus of herpes simplex virus 1 is a virulence determinant in human skin.PLoS Pathog. 2020 Dec 28;16(12):e1009166. doi: 10.1371/journal.ppat.1009166. eCollection 2020 Dec. PLoS Pathog. 2020. PMID: 33370402 Free PMC article.
-
Hidden regulation of herpes simplex virus 1 pre-mRNA splicing and polyadenylation by virally encoded immediate early gene ICP27.PLoS Pathog. 2019 Jun 17;15(6):e1007884. doi: 10.1371/journal.ppat.1007884. eCollection 2019 Jun. PLoS Pathog. 2019. PMID: 31206552 Free PMC article.
References
-
- Block, T. M., S. Deshmane, J. Masonis, J. Maggioncalda, T. Valyi-Nagi, and N. W. Fraser. 1993. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 192:618-630. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials